FDA approves Belsomra, a new prescription sleep drug

See the original posting on LA Times Science

The Food & Drug Administration on Wednesday approved U.S. marketing of the first in a new class of sleep drugs that targets the brain’s wakefulness centers to speed the onset of sleep and reduce nighttime awakening. The new medication, which goes by the generic name suvorexant, is to be…